1. Wei, J, Calhoun, E, Jacobsen, S. Urologic Diseases in America project: benign prostatic hyperplasia. J Urol 2005; 173: 1256–1261.
Google Scholar | Crossref | Medline | ISI2. Berry, SJ, Coffey, DS, Walsh, PC, et al. The development of human benign prostatic hyperplasia with age. J Urol 1984; 132: 474–479.
Google Scholar | Crossref | Medline | ISI3. Gratzke, C, Bachmann, A, Descazeaud, A, et al. EAU guidelines on the assessment of non-neurogenic male lower urinary tract symptoms including benign prostatic obstruction. Eur Urol 2015; 67: 1099–1109.
Google Scholar | Crossref | Medline | ISI4. Whelan, J, Bowen, J, Burke, N, et al. A prospective trial of GreenLight PVP (HPS120) versus transurethral resection of the prostate in the treatment of lower urinary tract symptoms in Ontario, Canada. Can Urol Assoc J 2013; 7: 335.
Google Scholar | Crossref | Medline5. GreenLight XPS for treating benign prostatic hyperplasia , https://www.nice.org.uk/guidance/mtg29 (2016, accessed 13 January 2019).
Google Scholar6. The Department of Economic and Social Affairs of the United Nations . World Population Ageing https://www.un.org/en/development/desa/population/publications/pdf/ageing/WPA2017_Highlights.pdf (2017, accessed 27 August 2019).
Google Scholar7. Raj, M, McDonald, C, Brooks, A, et al. Stopping anticoagulation before TURP does not appear to increase perioperative cardiovascular complications. Urology 2011; 78: 1380–1384.
Google Scholar | Crossref | Medline8. Descazeaud, A, Robert, G, Lebdai, S, et al. Impact of oral anticoagulation on morbidity of transurethral resection of the prostate. World J Urol 2010; 29: 211–216.
Google Scholar | Crossref | Medline9. Enver, M, Hoh, I, Chinegwundoh, F. The management of aspirin in transurethral prostatectomy: current practice in the UK. Ann R Coll Surg Engl 2006; 88: 280–283.
Google Scholar | Crossref | Medline10. Hahn, R, Farahmand, B, Hallin, A, et al. Incidence of acute myocardial infarction and cause-specific mortality after transurethral treatments of prostatic hypertrophy. Urology 2000; 55: 236–240.
Google Scholar | Crossref | Medline11. Levine, G, Bates, E, Bittl, J, et al. 2016 ACC/AHA guideline focused update on duration of dual antiplatelet therapy in patients with coronary artery disease: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines: an update of the 2011 ACCF/AHA/SCAI guideline for percutaneous coronary intervention, 2011 ACCF/AHA guideline for coronary artery bypass graft surgery, 2012 ACC/AHA/ACP/AATS/PCNA/SCAI/STS guideline for the diagnosis and management of patients with stable ischemic heart disease, 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction, 2014 AHA/ACC guideline for the management of patients with non–ST-elevation acute coronary syndromes, and 2014 ACC/AHA guideline on perioperative cardiovascular evaluation and management of patients undergoing noncardiac surgery. Circulation 2016; 134.
Google Scholar12. Schulz, S, Schuster, T, Mehilli, J, et al. Stent thrombosis after drug-eluting stent implantation: incidence, timing, and relation to discontinuation of clopidogrel therapy over a 4-year period. Eur Heart J 2009; 30: 2714–2721.
Google Scholar | Crossref | Medline | ISI13. Woo, H, Reich, O, Bachmann, A, et al. Outcome of GreenLight HPS 120-W laser therapy in specific patient populations: those in retention, on anticoagulants, and with large prostates (⩾80 mL). Eur Urol Suppl 2008; 7: 378–383.
Google Scholar | Crossref14. Chen, C, Lin, S, Chiang, P. Outcome of GreenLight HPS laser therapy in surgically high-risk patients. Lasers Med Sci 2012; 28: 1297–1303.
Google Scholar | Crossref | Medline15. Hueber, P, Bienz, M, Valdivieso, R, et al. Photoselective vaporization of the prostate for benign prostatic hyperplasia using the 180 Watt system: multicenter study of the impact of prostate size on safety and outcomes. J Urol 2015; 194: 462–469.
Google Scholar | Crossref | Medline16. Woo, H, West, K. Does prostate size impact upon perioperative outcomes associated with photoselective vaporization of the prostate using the 180W lithium triborate laser? Urol Ann 2015; 7: 17.
Google Scholar | Crossref | Medline17. Knapp, G, Chalasani, V, Woo, H. Perioperative adverse events in patients on continued anticoagulation undergoing photoselective vaporisation of the prostate with the 180-W Greenlight lithium triborate laser. BJU Int 2017; 119: 33–38.
Google Scholar | Crossref | Medline18. Reich, O, Gratzke, C, Bachmann, A, et al. Morbidity, mortality and early outcome of transurethral resection of the prostate: a prospective multicenter evaluation of 10,654 patients. J Urol 2008; 180: 246–249.
Google Scholar | Crossref | Medline | ISI19. Bachmann, A, Tubaro, A, Barber, N, et al. 180-W XPS GreenLight laser vaporisation versus transurethral resection of the prostate for the treatment of benign prostatic obstruction: 6-month safety and efficacy results of a European multicentre randomised trial – the GOLIATH Study. Eur Urol 2014; 65: 931–942.
Google Scholar | Crossref | Medline | ISI20. Bachmann, A, Tubaro, A, Barber, N, et al. A European multicenter randomized noninferiority trial comparing 180 W GreenLight XPS laser vaporization and transurethral resection of the prostate for the treatment of benign prostatic obstruction: 12-month results of the GOLIATH Study. J Urol 2015; 193: 570–578.
Google Scholar | Crossref | Medline21. Thomas, J, Tubaro, A, Barber, N, et al. A multicenter randomized noninferiority trial comparing GreenLight-XPS laser vaporization of the prostate and transurethral resection of the prostate for the treatment of benign prostatic obstruction: two-yr outcomes of the GOLIATH Study. Eur Urol 2016; 69: 94–102.
Google Scholar | Crossref | Medline22. Woo, H, Hossack, T. Photoselective vaporization of the prostate with the 120-W lithium triborate laser in men taking coumadin. Urology 2011; 78: 142–145.
Google Scholar | Crossref | Medline23. Sohn, J, Choi, Y, Kim, S, et al. Effectiveness and safety of photoselective vaporization of the prostate with the 120 W HPS GreenLight laser in benign prostatic hyperplasia patients taking oral anticoagulants. Korean J Urol 2011; 52: 178.
Google Scholar | Crossref | Medline24. Tao, W, Xue, B, Zang, Y, et al. The application of 120-W high-performance system GreenLight laser vaporization of the prostate in high-risk patients. Lasers Med Sci 2012; 28: 1151–1157.
Google Scholar | Crossref | Medline25. Elshal, A, Elkoushy, M, El-Nahas, A, et al. GreenLight™ laser (XPS) photoselective vapo-enucleation versus holmium laser enucleation of the prostate for the treatment of symptomatic benign prostatic hyperplasia: a randomized controlled study. J Urol 2015; 193: 927–934.
Google Scholar | Crossref | Medline26. Charbonneau, H, Pasquié, M, Peyronnet, B, et al. Stopping or maintaining Oral Anticoagulation in patients undergoing Photoselective vaporization of the prostate (SOAP) surgery for benign prostate obstruction: study protocol for a multicentre randomized controlled trial. Trials 2018; 19.
Google Scholar | Medline